Cargando…
Clinically Evaluated COVID-19 Drugs with Therapeutic Potential for Biological Warfare Agents
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak resulted in hundreds of millions of coronavirus cases, as well as millions of deaths worldwide. Coronavirus Disease 2019 (COVID-19), the disease resulting from exposure to this pathogen, is characterized, among other features,...
Autores principales: | Dechtman, Ido-David, Ankory, Ran, Sokolinsky, Keren, Krasner, Esther, Weiss, Libby, Gal, Yoav |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304720/ https://www.ncbi.nlm.nih.gov/pubmed/37375079 http://dx.doi.org/10.3390/microorganisms11061577 |
Ejemplares similares
-
Potential Prophylactic Treatments for COVID-19
por: Ben-Zuk, Noam, et al.
Publicado: (2021) -
Biological warfare agents
por: Thavaselvam, Duraipandian, et al.
Publicado: (2010) -
Detecting Biological Warfare Agents
por: Song, Linan, et al.
Publicado: (2005) -
Biological warfare agents as threats to potable water.
por: Burrows, W D, et al.
Publicado: (1999) -
Immunosensors for Assay of Toxic Biological Warfare Agents
por: Pohanka, Miroslav
Publicado: (2023)